Metraipolis › archive › dc_7712e14db297
Human safety of SPBN GASGAS for oral rabies vaccination of dogs — Europe PMC PMID:41525297
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41525297
- DOI
- 10.1371/journal.pntd.0013866
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T08:27:02.805Z
- SHA-256 of the archived text
22f3188183353a9e02010e906522990bf8e4fa07f437bb42d3b53e2cc523d21f- Stable URL of this page
https://metraipolis.com/documento/dc_7712e14db297
How to cite
Human safety of SPBN GASGAS for oral rabies vaccination of dogs — Europe PMC PMID:41525297 — Europe PMC (en), https://europepmc.org/article/MED/41525297 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7712e14db297 (Metraipolis archive dc_7712e14db297, sha256 22f3188183353a9e02010e906522990bf8e4fa07f437bb42d3b53e2cc523d21f)
BibTeX
@misc{dc7712e14db297,
title = {Human safety of SPBN GASGAS for oral rabies vaccination of dogs — Europe PMC PMID:41525297},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41525297},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7712e14db297; sha256 22f3188183353a9e02010e906522990bf8e4fa07f437bb42d3b53e2cc523d21f},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41525297. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Oral rabies vaccination (ORV) of dogs has been suggested as a complementary tool to injectable rabies vaccination, to access free-roaming dogs during mass dog vaccination campaigns. Stringent safety requirements have been developed and implemented for ORVs targeting wildlife and dogs. Part of the safety requirements involves conducting a risk assessment of the potential for human contact with the vaccine virus and the impact on human health. The former is predominantly determined by the bait distribution method and the latter by the safety profile of the vaccine construct. This risk assessment is focused on a commercially available ORV for dogs, SPBN GASGAS. Overall, it is concluded that although human contacts with the vaccine virus do occur infrequently, the risk of serious adverse events in humans is negligible due to the safety profile of the vaccine virus construct. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2026 (prima pubblicazione 2026-01-12). Identificativi: PMID 41525297 · PMCID PMC12795385 · DOI 10.1371/journal.pntd.0013866. Descrittori MeSH principali: Rabies; Dog Diseases; Rabies Vaccines; Vaccination. Pagina: https://europepmc.org/article/MED/41525297 — https://doi.org/10.1371/journal.pntd.0013866. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T08:18:50.408Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.